Asta Bio
Boston, United States · Founded 2024
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- astabiotx.com
About
Asta Bio is a Boston-based biotech developing targeted alpha-particle radiotherapies for cancer. The company pairs 211-Astatine, an alpha-emitting radioisotope, with its proprietary Radiobody targeting molecules to deliver precise radiation that destroys tumor cells by breaking their DNA while sparing healthy tissue. Founded in 2024 and backed by IndieBio, Asta Bio is advancing a preclinical pipeline; in 2025 it announced a discovery and development partnership with Alpha Nuclide to support clinical translation and manufacturing of its astatine-based therapies.
Summary
Asta Bio is a Biotech company based in Boston, United States, founded in 2024.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
European digital healthcare platform connecting patients with licensed doctors via video consulta...
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.